| Literature DB >> 36175314 |
Daniela Lemes Ferreira1, Gustavo Christofoletti2, Dayane Melo Campos1, Ana Luísa Janducci3, Maria Juana Beatriz Lima Candanedo3, Juliana Hotta Ansai4.
Abstract
OBJECTIVE: The aim of this study was to assess the effects of aquatic training on motor risk factors for falls in older people during the COVID-19 pandemic.Entities:
Keywords: Accidental Falls; Aged; Exercise; Hydrotherapy
Year: 2022 PMID: 36175314 PMCID: PMC9372189 DOI: 10.1016/j.jmpt.2022.08.002
Source DB: PubMed Journal: J Manipulative Physiol Ther ISSN: 0161-4754 Impact factor: 1.300
Figure 1Flow chart of participant recruitment
MMSE=Mini-Mental State Examination; Aquatic Training Group=ATG; Control Group=CG.
Clinical and sociodemographic characteristics of the total sample (n=49)
| 70.15±4.24 | 71.40±4.57 | 0.318 | ||
| 22 (91.7%) | 18 (72.0%) | 0.076 | ||
| 12 (50.0%) | 15 (60.0%) | 0.765 | ||
| 2.21±1.35 | 1.76±1.23 | 0.231 | ||
| 8 (33.3%) | 6 (24.0%) | 0.470 | ||
| 18 (75.0%) | 13 (52.0%) | 0.095 | ||
| 20 (83.3%) | 22 (88.0%) | 0.641 | ||
| 1 (4.2%) | 0 (0%) | 0.302 | ||
| 30.54±5.80 | 28.05±3.91 | 0.084 | ||
| 7.17±5.19 | 5.80±4.42 | 0.326 | ||
| 4.67±2.46 | 4.04±2.79 | 0.409 | ||
| 5.80±3.38 | 4.93±4.63 | 0.456 | ||
| 2 (8.3%) | 4 (16.0%) | 0.413 | ||
SAH - Systemic Arterial Hypertension; BMI - Body Mass Index; MBQE - Modified Baecke Questionnaire for the Elderly; kg/m² - kilogram per meter squared; n (%) - number of subjects (percentage); M±SD=mean±standard deviation; P value - significance level ≤0.05
Muscle strength and mobility outcomes in the final sample
| 5-times Sit-to-Stand test, seconds | 16.33±3.42 | 14.76±3.24 | 16.37±4.23 | 15.12±5.33 | 0.000; 0.966 | 0.001; 0.856 | 0.166; |
| TUG | |||||||
| Time, seconds | 12.51±2.72 | 11.51±3.21 | 12.04±2.35 | 11.51±2.42 | 0.017; 0.380 | 0.004; 0.614 | 0.003; 0.738 |
| Number of steps | 16.04±2.21 | 14.46±3.10 | 15.16±2.65 | 14.40±2.50 | 0.057; 0.107 | 0.013; 0.447 | 0.057; 0.106 |
| Time, seconds | 16.99±4.50 | 14.78±4.80 | 16.86±4.05 | 14.06±3.58 | 0.020; 0.344 | 0.001; 0.853 | 0.407; |
| Errors | 0.37±1.24 | 0.29±0.69 | 0.20±0.50 | 0.16±0.47 | 0.000; 0.961 | 0.018; 0.372 | 0.013; 0.439 |
| Time, seconds | 23.23±4.84 | 22.25±6.18 | 23.13±3.71 | 22.51±4.56 | 0.003; 0.715 | 0.000; 0.929 | 0.010; 0.501 |
| Number of steps | 21.63±3.53 | 19.75±3.37 | 21.16±2.73 | 20.80±3.59 | 0.073; 0.066 | 0.004; 0.686 | 0.032; 0.231 |
| Stops | 2.13±0.68 | 2.25±0.94 | 2.20±0.57 | 2.24±0.77 | 0.005; 0.624 | 0.002; 0.769 | 0.059; 0.101 |
| Errors | 0.08±0.28 | 0.08±0.28 | 0.20±0.70 | 0.04±0.20 | 0.027; 0.269 | 0.011; 0.484 | 0.097; |
| 14.82±57.77 | 29.85±19.67 | 25.70±18.33 | 34.26±14.26 | 0.003; 0.697 | 0.024; 0.296 | 0.042; 0.169 | |
| 0.89±0.39 | 0.99±0.61 | 0.95±0.43 | 0.96±0.50 | 0.021; 0.325 | 0.002; 0.773 | 0.018; 0.365 | |
TUG – Timed Up and Go Test; TUG-DT – TUG associated with cognitive-motor task; n - number of subjects; M±SD - mean±standard deviation; P value - significance level ≤0.05. Confounding variables: COVID-19 diagnosis, participating in the research during the COVID-19 pandemic
Postural stability outcomes in the final sample
| Area-COP (cm²) | 4.67±1.50 | 3.49±1.44 | 6.68±2.52 | 6.09±3.33 | 0.131; 0.275 | 0.283; 0.092 | 0.326; 0.067 |
| Amplitude-AP (cm) | -3.21±3.47 | -3.71±1.56 | -2.66±1.79 | -3.22±1.90 | 0.000; 0.969 | 0.021; 0.672 | 0.047; 0.523 |
| Amplitude-ML (cm) | -0.14±0.69 | 0.18±1.07 | -0.51±0.89 | -0.29±0.64 | 0.004; 0.859 | 0.097; 0.350 | 0.094; 0.359 |
| Velocity-AP (cm/s) | 1.15±0.23 | 1.17±0.26 | 1.44±0.28 | 1.34±0.24 | 0.103; 0.337 | 0.224; 0.142 | 0.057; 0.479 |
| Velocity-ML (cm/s) | 1.30±0.25 | 1.28±0.32 | 0.95±1.47 | 1.49±0.24 | 0.069; 0.434 | 0.006; 0.817 | 0.058; 0.474 |
| Area-COP (cm²) | 10.23±6.53 | 10.30±6.33 | 10.68±2.35 | 13.77±5.21 | 0.127; 0.282 | 0.044; 0.538 | 0.138; 0.261 |
| Amplitude-AP (cm) | -2.56±2.84 | -2.63±1.64 | -3.98±1.80 | -2.41±1.28 | 0.295; 0.084 | 0.029; 0.615 | 0.260; 0.109 |
| Amplitude-ML (cm) | -0.52±1.24 | -0.06±1.34 | -0.41±0.69 | -0.97±1.31 | 0.276; 0.097 | 0.053; 0.496 | 0.000; 0.966 |
| Velocity-AP (cm/s) | 1.67±0.58 | 1.60±0.50 | 2.04±0.28 | 2.03±0.29 | 0.018; 0.695 | 0.206; 0.161 | 0.027; 0.626 |
| Velocity-ML (cm/s) | 1.93±0.50 | 1.86±0.75 | 2.50±0.44 | 2.27±0.55 | 0.058; 0.475 | 0.192; 0.177 | 0.172; 0.204 |
| Area-COP (cm²) | 7.76±3.27 | 6.74±2.24 | 19.74±17.90 | 11.93±7.50 | 0.176; 0.200 | 0.237; 0.128 | 0.265; 0.105 |
| Amplitude-AP (cm) | -5.55±2.85 | -4.89±1.45 | -4.90±3.45 | -2.09±4.43 | 0.148; 0.243 | 0.094; 0.359 | 0.350; 0.055 |
| Amplitude-ML (cm) | -0.80±0.80 | -0.30±1.55 | -0.95±0.51 | -1.05±1.65 | 0.029; 0.619 | 0.089; 0.372 | 0.013; 0.735 |
| Velocity-AP (cm/s) | 1.82±0.62 | 1.72±0.51 | 3.27±1.83 | 2.47±0.73 | 0.192; 0.178 | 0.289; 0.088 | 0.277; 0.096 |
| Velocity-ML (cm/s) | 2.58±0.76 | 2.36±0.55 | 3.61±0.81 | 3.15±0.24 | 0.039; 0.558 | 0.448; | 0.259; 0.110 |
| Area-COP (cm²) | 33.25±31.20 | 36.70±19.37 | 83.80±58.51 | 34.95±13.05 | 0.370; | 0.180; 0.193# | 0.308; 0.076& |
| Amplitude-AP (cm) | -5.28±3.55 | -3.46±5.45 | -3.99±2.49 | -2.80±2.48 | 0.010; 0.772 | 0.024; 0.647 | 0.189; 0.182 |
| Amplitude-ML (cm) | -0.40±0.81 | -0.72±1.09 | -0.83±0.79 | -1.35±1.76 | 0.007; 0.802 | 0.081; 0.397 | 0.114; 0.310 |
| Velocity-AP (cm/s) | 3.72±1.34 | 4.29±2.25 | 6.52±2.55 | 5.82±1.98 | 0.098; 0.347 | 0.313; 0.074 | 0.001; 0.924 |
| Velocity-ML (cm/s) | 4.66±1.43 | 4.90±1.74 | 5.66±0.73 | 5.52±1.49 | 0.036; 0.576 | 0.101; 0.341 | 0.003; 0.882 |
FT-OE - standing posture, arms along the body, feet together, open eyes; FT-CE - same posture, feet together, closed eyes; TANDEM-OE - same posture, tandem position, open eyes; TANDEM-CE - same posture, tandem position, closed eyes; Area-COP - area of Center of Pressure displacement; Amplitude-AP - Average amplitude of Anteroposterior COP Displacement; Amplitude-ML - Average amplitude of Mediolateral COP Displacement; Velocity-AP – average velocity of COP displacement in anteroposterior plane; Velocity-ML – average velocity of COP displacement in mediolateral plane; Negative values in the anteroposterior and mediolateral planes represent displacement backward and to the left, respectively; n - number of subjects; M±SD - Mean±standard deviation; P value - significance level ≤0. 05; cm -centimeter; cm² - centimeter squared; cm/s - centimeter per second; #Baseline: p=0.099, 16 weeks: p=0.875 &Control Group: p=0.017, Aquatic Training Group: p=0.831. Confounding variables: COVID-19 diagnosis, participating in the research during the COVID-19 pandemic.
Muscle strength and mobility outcomes among volunteers who adhered at least 50% to the intervention
| 5-times Sit-to-Stand test, seconds | 16.91±1.41 | 14.81±2.89 | 16.37±4.23 | 15.12±5.33 | 0.837 | 0.939 | |
| TUG | |||||||
| Time, seconds | 12.22±2.33 | 10.95±2.02 | 12.04±2.35 | 11.51±2.42 | 0.099 | 0.747 | 0.949 |
| Number of steps | 15.80±2.44 | 14.20±2.61 | 15.16±2.65 | 14.40±2.50 | 0.455# | 0.189& | |
| Time, seconds | 17.97±5.11 | 14.69±5.51 | 16.86±4.05 | 14.06±3.58 | 0.634 | 0.966 | |
| Errors | 0.20±0.42 | 0.40±0.96 | 0.20±0.50 | 0.16±0.47 | 0.179 | 0.507 | 0.249 |
| Time, seconds | 23.66±5.94 | 21.94±5.19 | 23.13±3.71 | 22.51±4.56 | 0.350 | 0.992 | 0.401 |
| Number of steps | 21.10±4.01 | 19.40±2.95 | 21.16±2.73 | 20.80±3.59 | 0.074 | 0.476 | 0.401 |
| Stops | 2.50±0.70 | 2.10±0.73 | 2.20±0.57 | 2.24±0.77 | 0.378 | 0.826 | 0.165 |
| Errors | 0.10±0.31 | 0.20±0.42 | 0.20±0.70 | 0.04±0.20 | 0.089 | 0.440 | 0.052 |
| 22.26±14.93 | 30.64±22.21 | 25.70±18.33 | 34.26±14.26 | 0.516 | 0.741 | ||
| 0.94±0.38 | 1.04±0.49 | 0.95±0.43 | 0.96±0.50 | 0.179 | 0.700 | 0.412 | |
TUG – Timed Up and Go Test; TUG-DT – TUG associated with cognitive-motor task; n - number of subjects; M±SD - mean±standard deviation; P value - significance level ≤0.05.. #baseline: p=0.091, 16 weeks: p=0.832 &Control Group: p=0.218, Aquatic Training Group: p=0.001. Confounding variables: COVID-19 diagnosis, participating in the research during the COVID-19 pandemic.
Postural stability outcomes among volunteers who adhered at least 50% to the intervention
| Area-COP (cm²) | 4.81±1.63 | 3.66±1.55 | 6.68±2.52 | 6.09±3.33 | 0.528 | 0.174 | 0.076 |
| Amplitude-AP (cm) | -2.93±3.91 | -3.78±1.73 | -2.66±1.79 | -3.22±1.90 | 0.868 | 0.759 | 0.432 |
| Amplitude-ML (cm) | -0.20±0.69 | 0.39±1.04 | -0.51±0.89 | -0.29±0.64 | 0.764 | 0.203 | 0.333 |
| Velocity-AP (cm/s) | 1.14±0.25 | 1.17±0.29 | 1.44±0.28 | 1.34±0.24 | 0.336 | 0.177 | 0.583 |
| Velocity-ML (cm/s) | 1.30±0.28 | 1.27±0.36 | 0.95±1.47 | 1.49±0.24 | 0.474 | 0.843 | 0.526 |
| Area-COP (cm²) | 11.15±6.85 | 11.20±6.64 | 10.68±2.35 | 13.77±5.21 | 0.327 | 0.751 | 0.315 |
| Amplitude-AP (cm) | -2.35±3.13 | -2.91±1.67 | -3.98±1.80 | -2.41±1.28 | 0.668# | 0.196& | |
| Amplitude-ML (cm) | -0.31±1.26 | 0.43±1.13 | -0.41±0.69 | -0.97±1.31 | 0.086 | 0.269 | 0.796 |
| Velocity-AP (cm/s) | 1.74±0.62 | 1.63±0.55 | 2.04±0.28 | 2.03±0.29 | 0.563 | 0.256 | 0.503 |
| Velocity-ML (cm/s) | 1.96±0.56 | 1.91±0.82 | 2.50±0.44 | 2.27±0.55 | 0.474 | 0.259 | 0.278 |
| Area-COP (cm²) | 8.12±3.52 | 7.20±2.16 | 19.74±17.90 | 11.93±7.50 | 0.240 | 0.187 | 0.147 |
| Amplitude-AP (cm) | -5.50±3.19 | -5.09±1.53 | -4.90±3.45 | -2.09±4.43 | 0.208 | 0.374 | 0.102 |
| Amplitude-ML (cm) | -0.81±0.89 | 0.22±0.97 | -0.95±0.51 | -1.05±1.65 | 0.339 | 0.124 | 0.423 |
| Velocity-AP (cm/s) | 1.86±0.69 | 1.78±0.55 | 3.27±1.83 | 2.47±0.73 | 0.213 | 0.136 | 0.138 |
| Velocity-ML (cm/s) | 2.65±0.83 | 2.42±0.59 | 3.61±0.81 | 3.15±0.24 | 0.596 | 0.149 | |
| Area-COP (cm²) | 35.04±34.54 | 38.67±20.97 | 83.80±58.51 | 34.95±13.05 | 0.070 | 0.272 | 0.110 |
| Amplitude-AP (cm) | -5.65±3.84 | -3.16±6.04 | -3.99±2.49 | -2.80±2.48 | 0.566 | 0.669 | 0.126 |
| Amplitude-ML (cm) | -0.39±0.91 | -0.31±0.45 | -0.83±0.79 | -1.35±1.76 | 0.417 | 0.251 | 0.557 |
| Velocity-AP (cm/s) | 3.80±1.49 | 4.32±2.51 | 6.52±2.55 | 5.82±1.98 | 0.412 | 0.113 | 0.908 |
| Velocity-ML (cm/s) | 4.75±1.58 | 4.84±1.94 | 5.66±0.73 | 5.52±1.49 | 0.747 | 0.400 | 0.951 |
FT-OE - standing posture, arms along the body, feet together, open eyes; FT-CE - same posture, feet together, closed eyes; TANDEM-OE - same posture, tandem position, open eyes; TANDEM-CE - same posture, tandem position, closed eyes; Area-COP - area of Center of Pressure displacement; Amplitude-AP - Average amplitude of Anteroposterior COP Displacement; Amplitude-ML - Average amplitude of Mediolateral COP Displacement; Velocity-AP – average velocity of COP displacement in anteroposterior plane; Velocity-ML – average velocity of COP displacement in mediolateral plane; Negative values in the anteroposterior and mediolateral planes represent displacement backward and to the left, respectively; n - number of subjects; M±SD - Mean±standard deviation; P value - significance level ≤0. 05; cm - centimeter; cm² - centimeter squared; cm/s - centimeter per second; #Baseline: p=0.342, 16 weeks: p=0.614. &Control Group: p=0.015, Aquatic Training Group: p=0.307. Confounding variables: COVID-19 diagnosis, participating in the research during the COVID-19 pandemic.